Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management (Q34188848)

31 July 2017

1 reference

title

Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management (English)

1 reference

31 July 2017

1 reference

Assmann G

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

American Journal of Cardiology

31 July 2017

published in

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

2B-7B

1 reference

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Beyond LDL cholesterol reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Raising low levels of high-density lipoprotein cholesterol is an important target of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901448-5

10.1016/S0002-9149(01)01448-5

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference